ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1595

Concern About the COVID-19 Pandemic and Community Mobility Among Systemic Lupus Erythematosus Patients

Laura Plantinga1, Courtney Hoge1, Cristina Drenkard1, Charmayne Dunlop-Thomas1, Brad Pearce1, S Sam Lim2 and C. Barrett Bowling3, 1Emory University, Atlanta, GA, 2Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 3Duke University, Durham, NC

Meeting: ACR Convergence 2021

Keywords: COVID-19, physical function, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster IV: COVID-19 (1589–1613)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Opportunities for community mobility, which reflects both physical mobility and social participation, during the COVID-19 pandemic have been limited and may have been related to level of concern about the pandemic. We used data from an ancillary cohort study [Approaches to Positive, Patient-centered Experiences of Aging in Lupus (APPEAL)] to examine the association between level of concern about the pandemic and community mobility among individuals with systemic lupus erythematosus (SLE).

Methods: APPEAL subjects were recruited from the population-based Georgians Organized Against Lupus (GOAL) cohort of individuals with validated SLE. A total of 153 participants (mean age, 48 years; 95% female, 76% Black) were consented (10/6/2020-5/4/2021) for a single visit during the period the COVID-19 survey was administered. Responses to the item “How concerned are you about the COVID-19 pandemic?” (N=152) were dichotomized as very concerned vs. somewhat or not at all concerned. Community mobility was measured via the UAB Study of Aging Life-Space Assessment (score range, 0-120), with higher life-space scores representing greater community mobility (movement across greater distances from home, with greater frequency and less help). Scores were described overall and by level of concern [medians (interquartile ranges)], and Wilcoxon rank sum tests were used to obtain p values. The percentages of participants reaching each life-space level without personal assistance were calculated and compared by level of concern using chi-square tests. Finally, life-space scores were dichotomized as low (at or below the median, ≤48) vs. high (above the median, >48) in logistic models with concern as the exposure, adjusting for age, gender, and race.

Results: Life-space scores were lower among participants who were very vs. somewhat/not at all concerned about the pandemic [35 (16-72) vs. 58 (24-72); p = 0.2]. Overall, without personal assistance, 86.9% of participants reached the life-space level of home (excluding bedroom); 81.7%, outside the home; 61.4%, neighborhood; 60.1%, town; and 40.5% out of town/unlimited. Percentages of patients reaching each life-space level without personal assistance were lower among those who were very concerned about the pandemic, compared to those who were somewhat/not all concerned (Figure). Those who were very vs. somewhat/not at all concerned were 68% more likely to have a low vs. high life-space score [OR=1.68 (95% CI 0.79-3.21)]; adjustment for demographics slightly attenuated this association [OR=1.54 (95% CI 0.79-3.00)]. The associations were similar among older [≥50 years; OR=1.61 (95% CI 0.62-4.17)] and younger [< 50 years; OR=1.73 (95% CI 0.71-4.21); p-interaction=0.8] patients. Most of the differences and associations were not statistically significant.

Conclusion: In this cross-sectional study of individuals with SLE, we found that life-space scores were low overall and that these scores were even lower among those who expressed high level of concern about the COVID-19 pandemic. Future studies should explore whether these low levels of community mobility persist beyond the pandemic and whether they are associated with poor physical and/or mental health outcomes in SLE.

Percentages of SLE patients reaching life-space levels without personal assistance, by level of concern about the COVID_19 pandemic (very concerned vs. somewhat/not at all concerned). *p < 0.1; **p < 0.05.


Disclosures: L. Plantinga, None; C. Hoge, None; C. Drenkard, GSK, 1, 5; C. Dunlop-Thomas, None; B. Pearce, None; S. Lim, Bristol Myers Squibb, 5, GlaxoSmithKline, 2, ACR, 4, AstraZeneca, 5, Pfizer, 2, UCB, 2; C. Bowling, None.

To cite this abstract in AMA style:

Plantinga L, Hoge C, Drenkard C, Dunlop-Thomas C, Pearce B, Lim S, Bowling C. Concern About the COVID-19 Pandemic and Community Mobility Among Systemic Lupus Erythematosus Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/concern-about-the-covid-19-pandemic-and-community-mobility-among-systemic-lupus-erythematosus-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/concern-about-the-covid-19-pandemic-and-community-mobility-among-systemic-lupus-erythematosus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology